Bifidobacterium lactis – MB2409 (DSM 23733)

Tabella dei contenuti

Clinical indications

cholesterol management, Cardiovascular health

Area of use

Cardiology strain | Cholesterol management

Characteristics

FUNCTIONALITY
Cardiovascular health • Cholesterol lowering

Scientific support

In vitro and in vivo testing
Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.


Cardiology blend | Cholesterol management

  • Bifidobacterium lactis – MB2409 (DSM 23733)
  • Bifidobacterium bifidum – MB109 (DSM 23731)
  • Bifidobacterium longum – 04 (DSM 23233)

Characteristics

DAILY DOSAGE IN CLINICAL STUDY
1 billion CFU/strain


FUNCTIONALITY
Cardiovascular health • Cholesterol lowering

Scientific support

Human clinical trial
Guardamagna O. et al. Bifidobacteria supplementation: effects on plasma lipid profile in dyslipidemic children. Nutrition (2014), doi: 10.1016/ j.nut. 2014.01.014.

In vitro and in vivo testing
Bordoni et al. Cholesterol-lowering probiotics: in vitro selection and in vivo testing of Bifidobacteria. Appl. Microbiol. Biotechnol. 2013. 97:8273-8281.